C07D 233/42
Sulfur atoms
C07D233/42 (Sulfur atoms) appears on 168 US grants and 113 published applications in this corpus.
Search patents in C07D- Granted patents
- 168
- Published applications
- 113
- Assignees
- 105
- Inventors
- 479
- Latest grant
- 3 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 7 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 5 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 9 |
| 2003 | 8 | 13 |
| 2004 | 3 | 14 |
| 2005 | 7 | 10 |
| 2006 | 9 | 10 |
| 2007 | 7 | 3 |
| 2008 | 6 | 11 |
| 2009 | 4 | 2 |
| 2010 | 6 | 5 |
| 2011 | 3 | 3 |
| 2012 | 4 | 5 |
| 2013 | 5 | 4 |
| 2014 | 3 | 2 |
| 2015 | 2 | 3 |
| 2016 | 2 | 0 |
| 2017 | 2 | 1 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 2 | 2 |
| 2021 | 2 | 4 |
| 2022 | 2 | 2 |
| 2023 | 1 | 2 |
| 2024 | 3 | 0 |
| 2025 | 0 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Compounds and methods for the targeted degradation of androgen receptor3 Sep 2024US 12,077,509 B2Arvinas Operations, Inc.
- Compounds and methods for the targeted degradation of androgen receptor23 Apr 2024US 11,964,945 B2Arvinas Operations, Inc.
- Compounds and methods for the targeted degradation of androgen receptor9 Apr 2024US 11,952,347 B2Arvinas Operations, Inc.
- Modulators of eukaryotic initiation factor 2B, compositions and methods26 Dec 2023US 11,851,440 B2Denali Therapeutics Inc.
- Compounds and methods for the targeted degradation of androgen receptor1 Feb 2022US 11,236,051 B2Arvinas Operations, Inc.
- Modulators of eukaryotic initiation factor 2b, compositions and methods25 Dec 2025US 2025/0388595 A1Denali Therapeutics Inc.
- Selective hdac6 inhibitor4 Dec 2025US 2025/0368608 A1Dana-Farber Cancer Institute, Inc.
- Compounds and methods for the targeted degradation of androgen receptor30 Jan 2025US 2025/0034096 A1Arvinas Operations, Inc.
- Compounds and methods for the targeted degradation of androgen receptor19 Oct 2023US 2023/0331681 A1Arvinas Operations, Inc.
- Compounds and methods for blocking apoptosis and inducing autophagy13 Jul 2023US 2023/0219898 A1President and Fellows of Harvard College
Most cited
By later US patents
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Inhibitors of glutaminyl cyclase53US 7,371,871 B2Probiodrug AG · 2008
- Aryl substituted nitrogen heterocyclic antidepressants49US 5,128,358 APfizer Inc. · 1992
- Imidazolidinones, and imidazolidinethiones, process and intermediates for the preparation thereof, and use of said compounds as herbicidal agents42US 4,608,079 AAmerican Cyanamid Company · 1986